Supernus Pharmaceuticals
SUPN
SUPN
222 hedge funds and large institutions have $1.45B invested in Supernus Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 80 increasing their positions, 76 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 225 → 222 (-3)
13% less capital invested
Capital invested by funds: $1.67B → $1.45B (-$216M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
222
Holding in Top 10
2
Calls
$6M
Puts
$838K
Top Buyers
| 1 | +$15.4M | |
| 2 | +$10.4M | |
| 3 | +$8.83M | |
| 4 |
Millennium Management
New York
|
+$8.34M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$7.92M |
Top Sellers
| 1 | -$25M | |
| 2 | -$14.3M | |
| 3 | -$10.4M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$6.34M |
| 5 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
-$5.2M |